Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

<p>Aims: Ventricular arrhythmia triggers sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM), yet electrophysiological biomarkers are not used for risk stratification. Our aim was to identify distinct HCM phenotypes based on ECG computational analysis, and characterize differences...

Bibliografski detalji
Glavni autori:	Lyon, A, Ariga, R, Minchole, A, Mahmod, M, Ormondroyd, E, Laguna, P, de Freitas, N, Neubauer, S, Watkins, H, Rodriguez, B
Format:	Journal article
Izdano:	Frontiers Media 2018

Slični predmeti

Risk stratification in hypertrophic cardiomyopathy based on QRS and T wave morphological biomarkers identifies three phenotypic subgroups
od: Lyon, A, i dr.
Izdano: (2016)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
od: Chow, J, i dr.
Izdano: (2024)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
od: Ji-Jian Chow, i dr.
Izdano: (2024-08-01)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
od: Lyon, A, i dr.
Izdano: (2018)

Extraction of morphological QRS-based biomarkers in hypertrophic cardiomyopathy for risk stratification using L1 regularized logistic regression
od: Lyon, A, i dr.
Izdano: (2016)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
od: Passini, E, i dr.
Izdano: (2015)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
od: Zakariye Ashkir, MD, i dr.
Izdano: (2024-01-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
od: Coleman, JA, i dr.
Izdano: (2024)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
od: James A. Coleman, i dr.
Izdano: (2024-04-01)

ECG-based estimation of dispersion of APD restitution as a tool to stratify sotalol-induced arrhythmic risk.
od: Mincholé, A, i dr.
Izdano: (2015)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
od: Coleman, JA
Izdano: (2024)

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
od: Masliza Mahmod, i dr.
Izdano: (2022-06-01)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
od: Safa Daghem, i dr.
Izdano: (2024-01-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
od: S. M. Komissarova, i dr.
Izdano: (2021-05-01)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
od: Ariga, R, i dr.
Izdano: (2017)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
od: Ariga, R, i dr.
Izdano: (2018)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
od: Ariga, R, i dr.
Izdano: (2019)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
od: Coleman, J
Izdano: (2024)

Pseudo-arrhythmic ECG artifact
od: Satyajeet Singh, i dr.
Izdano: (2012-01-01)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
od: Sílvia Aguiar Rosa, i dr.
Izdano: (2021-12-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
od: Neubauer, S, i dr.
Izdano: (2019)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
od: Blair, E, i dr.
Izdano: (2003)

Distinct Phenotypic Groups and Related Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
od: Soongu Kwak, i dr.
Izdano: (2024-10-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
od: Neubauer, S, i dr.
Izdano: (2019)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
od: Hudsmith, L, i dr.
Izdano: (2006)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
od: George Joy, MD, i dr.
Izdano: (2024-01-01)

Discrepancy between pathological progression and clinical stability in a young patient with hypertrophic cardiomyopathy
od: Raman, B, i dr.
Izdano: (2018)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
od: Raman, B, i dr.
Izdano: (2018)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
od: Lyon, A, i dr.
Izdano: (2019)

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
od: Raman, B, i dr.
Izdano: (2021)

Computational techniques for ECG analysis and interpretation in light of their contribution to medical advances
od: Lyon, A, i dr.
Izdano: (2018)

Restrictive cardiomyopathy and hypertrophic cardiomyopathy overlap: the importance of the phenotype
od: Juan Pablo Kaski, i dr.
Izdano: (2012-10-01)

Sudden death in hypertrophic cardiomyopathy.
od: Watkins, H
Izdano: (2000)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
od: Petersen, SE, i dr.
Izdano: (2009)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
od: Doste, R, i dr.
Izdano: (2022)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
od: Coleman, J, i dr.
Izdano: (2023)

Atypical ECG Presentation of Hypertrophic Cardiomyopathy stimulating Acute Myocardial Infarction
od: Rikesh Tamrakar
Izdano: (2021-04-01)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
od: Raman, B, i dr.
Izdano: (2017)

A Genotype-phenotype Taxonomy of Hypertrophic Cardiomyopathy
od: Lara Curran, BSc, i dr.
Izdano: (2024-01-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
od: Blair, E, i dr.
Izdano: (2001)